New Hampshire Health Report
SEE OTHER BRANDS

Get your fresh news on health and wellness in New Hampshire

New Hampshire Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire Health Report.

Press releases published on June 13, 2025

Biomea Fusion Presents Updated Preliminary Clinical Data for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia at EHA 2025

Biomea Fusion Presents Updated Preliminary Clinical Data for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia at EHA 2025

REDWOOD CITY, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced updated preliminary clinical data from the ongoing Phase I …

RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives

RetinalGenix Technologies Welcomes Dr. Taimour Langaee as Advisor for DNA GPS Pharmacogenetics Initiatives

APOLLO BEACH, Fla., June 13, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), a pioneer in advanced retinal imaging and precision medicine, is pleased to announce the appointment of Dr. Taimour Langaee, …

ITM to Provide COMPETE Trial Insights at SNMMI 2025 Annual Meeting in Oral Presentation and Satellite Symposium

ITM to Provide COMPETE Trial Insights at SNMMI 2025 Annual Meeting in Oral Presentation and Satellite Symposium

Garching / Munich, Germany, June 13, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that it will provide further analysis from its recently completed Phase 3 COMPETE trial in an oral …

Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 2, 2025

Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 2, 2025

REGULATED INFORMATION June 13, 2025, 7:00am CET / 1:00am ET NYXOAH SA (Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium (hereinafter the “Company”) Invitation to attend the extraordinary shareholders’ meeting of the …

Avextra Cannabisextrakt kann Symptombelastung bei Palliativpatient:innen potenziell verringern

Avextra Cannabisextrakt kann Symptombelastung bei Palliativpatient:innen potenziell verringern

Neue Studie zeigt positive Ergebnisse bei der Behandlung von Palliativpatient:innen im Spätstadium mit Cannabis-basierten Arzneimitteln Bensheim – 13. Juni 2025. Laut Angaben der WHO benötigen jedes Jahr schätzungsweise 56,8 Millionen Menschen weltweit …

Invitation à assister à l'assemblée générale extraordinaire des actionnaires de la Société qui se tiendra le 2 juillet 2025

Invitation à assister à l'assemblée générale extraordinaire des actionnaires de la Société qui se tiendra le 2 juillet 2025

INFORMATIONS RÉGLEMENTÉES le 13 juin 2025, 7:00h CET / 1:00h ET NYXOAH SA (Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgique (ci-après la « Société ») Invitation à assister à l'assemblée générale extraordinaire des …

Avextra Cannabis extract can potentially reduce symptom burden for late palliative patients

Avextra Cannabis extract can potentially reduce symptom burden for late palliative patients

New Study Demonstrates Significant Symptom Relief for Late-Stage Palliative Patients Treated with Cannabis-based Medicines Bensheim, Germany – 13th June 2025 – According to the World Health Organization, an estimated 56.8 million palliative care patients …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service